The potential therapeutic applications and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) in cancers.
The metastasis-associated in colon cancer-1 (MACC1) gene was identified in 2009. Expression of MACC1 was found to be significantly upregulated in primary and metastatic colon carcinomas compared to normal tissues or adenomas. The induction of MACC1 occurs at the crucial step of transition from a benign to a malignant phenotype. The aim of this review was to summarise current results of non-clinical and clinical studies on the role of MACC1 in the carcinogenesis and progression of cancer, as well its potential therapeutic and prognostic significance. The gene encoding the HGF receptor MET is a transcriptional target of MACC1. In addition to promoting the proliferation, invasion, and migration of colon cancer cells in cell culture and tumour growth and metastasis in mouse models, MACC1 also contributes to carcinogenesis and progression of colorectal cancer through the β-catenin signalling pathway and mesenchymal-epithelial transition. MACC1 knockdown with si/sh RNA was investigated in cell lines of different types of cancer. MACC1 is a promising therapeutic target for antitumour and antimetastatic intervention strategies for cancers. Here, it is presented as a potential independent prognostic indicator of reduced overall survival as well as of the occurrence of distant metastasis in patients with different types of cancer.
Department of Pathobiochemistry and Clinical Chemistry, Faculty of Pharmacy, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Poland.
Ewa Katarzyna
EK
Kopczyńska
cancer therapy; metastasis-associated in colon cancer-1 (MACC1); prognosis
PLoS One. 2014 Jun 20;9(6):e100161
24949951
Mol Cancer. 2012 Apr 25;11:23
22533346
Oncol Rep. 2015 Feb;33(2):713-20
25482402
Med Oncol. 2014 Jan;31(1):790
24310811
Mol Biol Rep. 2014 Mar;41(3):1247-56
24469707
J Transl Med. 2011 Sep 29;9:166
21955323
Anticancer Res. 2011 Mar;31(3):777-80
21498695
Oncogene. 2015 May 21;34(21):2700-10
25043301
Chin J Cancer Res. 2011 Jun;23(2):153-9
23483020
Cell Physiol Biochem. 2015 ;35(3):983-96
25660117
Tumour Biol. 2014 Mar;35(3):2537-48
24163085
Int J Biochem Cell Biol. 2009 Dec;41(12):2356-9
19666136
Clin Cancer Res. 2009 Apr 1;15(7):2207-14
19318488
Ann Surg. 2012 Nov;256(5):763-71; discussion 771
23095620
Anticancer Res. 2010 Jul;30(7):2689-92
20682999
Biomed Res Int. 2015;2015:252043
26090393
Clin Cancer Res. 2012 Feb 1;18(3):737-47
22179665
Arch Gynecol Obstet. 2014 Jun;289(6):1271-80
24346124
Oncotarget. 2014 Jun 15;5(11):3756-69
25003996
Anticancer Res. 2011 Apr;31(4):1141-5
21508357
Acta Biochim Pol. 2009;56(2):317-23
19499089
Eur J Cancer. 2014 Aug;50(12):2134-41
24910416
World J Gastroenterol. 2015 Jan 7;21(1):333-41
25574109
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4150-5
25120795
Cancer Cell Int. 2013 Dec 10;13(1):121
24325214
Nat Rev Mol Cell Biol. 2003 Dec;4(12):915-25
14685170
J Exp Clin Cancer Res. 2011 Sep 16;30:83
21923915
Cell Cycle. 2009 Aug;8(15):2467-9
19556890
Mol Cancer. 2015 Feb 14;14 :38
25742883
Nat Med. 2009 Jan;15(1):59-67
19098908
Zhonghua Zhong Liu Za Zhi. 2014 Jul;36(7):496-500
25327653
Mol Oncol. 2013 Oct;7(5):929-43
23800415
Neuro Oncol. 2013 Dec;15(12):1696-709
24220141
Int J Med Sci. 2014 Jan 21;11(3):268-75
24516351
PLoS One. 2012;7(11):e49249
23166620
Int J Cancer. 2013 Sep 15;133(6):1419-30
23457029
BMC Cancer. 2015 Mar 21;15:160
25884643
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014 Feb;36(1):47-51
24581128
J Thorac Cardiovasc Surg. 2011 Apr;141(4):895-8
21093878
Zhonghua Yi Xue Za Zhi. 2013 Aug 27;93(32):2584-6
24351603
Pathol Oncol Res. 2013 Oct;19(4):821-32
23812675
PLoS One. 2013;8(4):e60821
23573286
Mol Med Rep. 2015 Sep;12(3):3423-31
26043756
Pathol Oncol Res. 2013 Oct;19(4):749-53
23737034
Oncol Lett. 2014 Aug;8(2):891-897
25009663
J Mol Med (Berl). 2010 Jan;88(1):11-8
19787327
Clin Cancer Res. 2011 May 15;17(10):3146-56
21447729
Zhongguo Fei Ai Za Zhi. 2012 Jul;15(7):399-403
22814258
Anticancer Res. 2010 Sep;30(9):3441-4
20944120
Cancer Lett. 2015 Feb 1;357(1):242-53
25444928
Ann Surg. 2013 Jun;257(6):1089-95
23665971
Clin Exp Metastasis. 2012 Aug;29(6):573-83
22484916
Oncol Lett. 2012 Oct;4(4):783-791
23205101
Am J Clin Pathol. 2013 Nov;140(5):701-7
24124150
Cell Biosci. 2013 Mar 18;3(1):16
23497677
Int J Med Sci. 2014 Jan 05;11(2):142-50
24465159
Oncotarget. 2015 May 10;6(13):11492-506
25895023
BMC Cancer. 2012 Jan 17;12:20
22251819
Tumour Biol. 2014 Feb;35(2):1343-50
24065195
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Mar;32(3):312-6
22445973
Oncotarget. 2015 Jun 20;6(17):15222-34
25945841
Mol Cancer. 2012 Jul 29;11:49
22838389
Oncol Lett. 2014 Nov;8(5):2305-2309
25295116
Int J Clin Exp Med. 2015 Apr 15;8(4):4769-77
26131051
PLoS One. 2013 May 23;8(5):e64235
23717574
Tumour Biol. 2014 Apr;35(4):3771-8
24425103
Tumour Biol. 2014 Jan;35(1):815-9
23982875
Cancer Res. 2009 Oct 1;69(19):7495-8
19773429
Mol Cell Biochem. 2013 Apr;376(1-2):21-32
23232575
J Transl Med. 2013 Feb 15;11:41
23414367
Asian Pac J Cancer Prev. 2014;15(2):999-1003
24568531